Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Colorectal Neoplasms 5Stomach Neoplasms 4Sarcoma 2Endometrial Neoplasms 2Uterine Neoplasms 1Uterine Cervical Neoplasms 1Postoperative Complications 1Ovarian Neoplasms 1Neoplasms 1Motor Activity 1Lymphoma, Follicular 1Lung Neoplasms 1Gynecologic Surgical Procedures 1Gynecologic Cancer 1Gastrointestinal Neoplasms 1Frailty 1Coma 1Colonic Neoplasms 1Cerebrovascular Disorders 1Carcinoma, Hepatocellular 1Brain Injuries, Traumatic 1

Interventions

Carboplatin 340Cisplatin 238Paclitaxel 203Radiotherapy 195Pemetrexed 187Docetaxel 169Gemcitabine 157pembrolizumab 141Erlotinib Hydrochloride 107Etoposide 99Magnetic Resonance Spectroscopy 93Bevacizumab 91Specimen Handling 76Nivolumab 73Radiosurgery 72durvalumab 69Vinorelbine 54osimertinib 53Gefitinib 49Drug Therapy 49atezolizumab 42Irinotecan 42Radiation 40Topotecan 39Biopsy 39Standard of Care 38Cyclophosphamide 38Cetuximab 35Blood Specimen Collection 33Taxes 32

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Lung Neoplasms × Enhanced Recovery After Surgery × Clear all
NCT04451473 2022-11-16

Lung Surgery With Enhanced Recovery VS. Lung Surgery Without Enhanced Recovery

The Second Hospital of Shandong University

Phase NA Recruiting
350 enrolled
Thoracic

Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡